Patent · US Active

Sustained release formulations of nalbuphine

US10406106B2 · kind B2 · utility

0Cited by

35References

21Claims

0Family size

Assignee

ENDO PHARMACEUTICALS INC. · US

Inventors

Anand R. Baichwal · Wappingers Falls, US
Philip A. Goliber · Lasne, BE
Anthony E. Carpanzano · New Milford, US
Thomas Sciascia · Belmont, US
Donald Diehl, II · New Fairfield, US
Brian Vogler · North White Plains, US
David Verbel · New York, US
Stanley Au · Bethesda, US

Key dates

Filing date	Nov 21, 2018
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Nov 21, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.